0000899243-21-025367.txt : 20210622
0000899243-21-025367.hdr.sgml : 20210622
20210622185119
ACCESSION NUMBER: 0000899243-21-025367
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210617
FILED AS OF DATE: 20210622
DATE AS OF CHANGE: 20210622
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHELLER RICHARD H
CENTRAL INDEX KEY: 0001214133
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38959
FILM NUMBER: 211036702
MAIL ADDRESS:
STREET 1: C/O GENENTECH INC
STREET 2: 1 DNA WAY MS 49
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080-4990
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BridgeBio Pharma, Inc.
CENTRAL INDEX KEY: 0001743881
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 421 KIPLING STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: (650) 391-9740
MAIL ADDRESS:
STREET 1: 421 KIPLING STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94301
FORMER COMPANY:
FORMER CONFORMED NAME: BridgeBio Pharma LLC
DATE OF NAME CHANGE: 20180618
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-17
0
0001743881
BridgeBio Pharma, Inc.
BBIO
0001214133
SCHELLER RICHARD H
C/O BRIDGEBIO PHARMA, INC.
421 KIPLING STREET
PALO ALTO
CA
94301
1
1
0
0
Chairman of R&D
Stock Option (right to buy)
62.63
2021-06-17
4
A
0
38895
0.00
A
2031-06-16
Common Stock
38895
38895
D
The stock option vests and becomes exercisable in three annual installments after June 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date.
/s/ Brian Stephenson, Attorney-in-Fact
2021-06-22